Switzerland· 54055013
Tasmar 100 mg, Filmtabletten
A tolcapone product containing tolcaponum, registered in Switzerland by Viatris Pharma GmbH and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Tolcapone is registered in 15 of 19 countries.
Countries holding a registration under ATC N04BX01 (tolcapone), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Tolcapone · ATC N04BX01
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tolcapone costs, country by country.
Normalised to the WHO defined daily dose (0.45 g), the median price runs from $6.12 in France to $9.92 in Switzerland — a ×1.6 gap.
- Switzerland: $9.92 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tolcapone · price per daily dose (0.45 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.92
- IT Italy$8.47
- FR France$6.12
The record
At a glance
Swissmedic (Switzerland)- Active substance
- tolcaponum
- Manufacturer
- Viatris Pharma GmbH
- Country
- Switzerland (CH)
- ATC code
- N04BX01
- ATC class
- Tolcapone
- Defined daily dose
- 0.45 g, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768054055013030 StkCHF 60.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
88 interactions on record for tolcapone.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tolcapone · interactions on record
88 records
- 6 severe
- 74 moderate
- 2 minor
- 6 info
Most severe, free to view
- ProcarbazineL01XB01severe
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tolcapone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTASMARVIATRIS HEALTHCARE LIMITED, Dublin
- IrelandTasmar 100 mg film-coated tabletsViatris Healthcare Limited
- United StatesTasmarBausch Health US LLC
- NetherlandsTasmar 100 mg , filmomhulde tablettenViatris Healthcare Limited
- PolandTasmarViatris Healthcare Limited
- SwedenTasmar 100 mg Filmdragerad tablettViatris Healthcare Limited
- FranceTASMAR 100 mg, comprimé pelliculéVIATRIS HEALTHCARE (IRLANDE)
- SpainTASMAR 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULAViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Tolcapon Neuraxpharm
- Iceland · Tasmar
- Liechtenstein · Tasmar
- Norway · Tasmar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/993fdd6c-d20e-4cec-9bc6-169ad0d720ed GET /v1/drugs/993fdd6c-d20e-4cec-9bc6-169ad0d720ed?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "tolcaponum 100 mg",
"valid_from": "1997-03-15",
"limitations": null,
"galenic_form": "Filmtabl 100 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1997-03-15",
"self_retention_pct": 10
}See everything about tolcapone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.